Searched for
NOVO NORDISK INSULIN
Shantha Biologics to Make Injectable Drug Cartridges for Novo NordiskShantha Biologics has secured a significant contract with Danish pharmaceutical giant Novo Nordisk to manufacture cartridges for injectable...- Kiran Mazumdar-Shaw eyes crown of world’s top insulin supplier for BioconIndian drugmaker Biocon aims to be the world's top insulin supplier within five years, capitalising on growing demand as major pharmaceutic...
- Novo Nordisk bets on cheaper Ozempic to dominate India’s booming weight-loss marketNovo Nordisk has launched Ozempic in India at a competitive price, aiming to capture a significant share of the growing weight-loss market....
- Novo Nordisk warns patients after theft of weight-loss, diabetes drugsNovo Nordisk urges customers to purchase medications solely from authorized pharmacies with valid prescriptions after a theft of products, ...
- Is Novo Nordisk facing its “Nokia moment”? Stock tumbles to $50 from a year-high of $139 amid disruptive rivals and shifting market forcesNovo Nordisk’s stock has tumbled from record highs after slashing its 2025 outlook, as fierce competition, leadership changes, and legal ch...
- Domestic drug companies in a sweet spot as global players look beyond insulinIndian drug cos are increasing their presence in the insulin market. They are competing with multinational corporations. Affordable insulin...
- Novo Nordisk to phase out key drug, insulin cos spot big biz opportunityNovo Nordisk is set to discontinue some forms of its Mixtard insulin, including pen and cartridge versions, in India, coinciding with the a...
- Novo Nordisk to discontinue Human Mixtard, India's largest selling insulin brandNovo Nordisk will discontinue Human Mixtard, a top-selling insulin in India. This decision aligns with the company's global strategy. They ...
- Novo Nordisk gets approval to carry out clinical trials on weekly insulinNovo Nordisk has received approval from the Drug Controller General of India to conduct phase-III studies for its new weekly insulin inject...
- Novo Nordisk India and Torrent Pharma expand their insulin manufacturing facilityTorrent Pharmaceuticals and Novo Nordisk began their partnership 25 years ago in 1992 with the manufacture and launch of insulin in 40 IU v...
- Novo Nordisk searches for tablet to replace insulin shotsThe company that reaped nearly 80% of its $16 billion sales from insulin products last year is hopeful for a regulatory approval for its fi...
- Health to become more vital politically in India: Novo Nordisk CEO Lars Rebien Sørensen"India has a high incidence of non-communicable diseases, especially diabetes, and it is mostly because it is poorly regulated," said Søren...
- Novo Nordisk launches diabetes drug Ryzodeg in IndiaNovo Nordisk launched it's combination diabetic drug Ryzodeg, priced at Rs 1,595 for 300 units, for people with type II diabetes in India.
- Novo Nordisk to launch insulin injection Tresiba in IndiaInsulin player Novo Nordisk said it is launching long-lasting insulin injection Tresiba in the country soon.
- Novo Nordisk to rope in health workers for diabetes care to poorSeveral diabetic patients require insulin injections on a life-long basis, and it is difficult for the economically under-privileged to qui...
- We plan to expand clinical research in India: Novo Nordisk President and CEOIn an interview with ET, Novo Nordisk's president and CEO Lars Rebien Sorensen talks of the growing transfer of accounting and patenting wo...
- Novo in 3-way pact for insulin from stem cellsPharma firm Novo Nordisk, stem cell biotechnology firm Cellartis and Sweden’s Lund University Stem Cell Center have announced a collaborati...
- Danish drug co Novo Nordisk to set up data centreNovo Nordisk, a speciality pharma company with global leadership in the diabetes care market, has decided to set up its global data managem...
- India fast emerging as data management hubNovo Nordisk, a speciality pharma company with global leadership in the diabetes care market, has decided to set up its global data managem...
- How Dr Reddy's chased diabetes molecule dreamDr Reddy’s pursuit of past 13 years for the type 2 diabetes molecule is in its last lap, with the product entering the final phase of clini...
Load More
